Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>In addition to favorable effects on glucose control and cardiovascular outcomes, treatment with empagliflozin was associated with meaningful reductions in adverse renal outcomes.</p>

Empagliflozin Improves Renal Outcomes in Type 2 Diabetes